Polynovo Share Price and Company Fundamentals

-0.040 (-1.970%)
52 week
0.835 - 2.25

Last traded: Today at 5:10 AM

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield



Market cap


Enterprise value


Company profile

Primary activities PolyNovo develops and commercialises innovative medical devices using its NovoSorb technology in the treatment of burns, surgical wounds and Negative Pressure Wound Therapy.
Industry / Sector Medical Devices / Healthcare
Full time employees 152
Website https://polynovo.com
Mailing address 320 Lorimer Street Unit 2 Port Melbourne VIC 3207 Australia
Phone / Fax 61 3 8681 4050 / 61 3 8681 4099


Polynovo does not pay dividends.

Company Executives

As of Dec 2022, following are the company executives and directors listed on Polynovo.

Name Title Age Total Pay
Mr. Jan-Marcel Gielen C.A. CFO & Company Sec. 244.75k
Dr. David McQuillan Ph.D. Chief Technical & Scientific Officer 69.54k
Mr. Swami Raote BPHARM, M.B.A. CEO & Director
Mr. Ahmed Hassan Director of Operations
Ms. Teena Chadha APAC Marketing & Distributor Mang.
Ms. Monica Benyk HR Mang.
Dr. Tim Moore Principal Scientist
Mr. Edward Graubart Sr. VP of Sales & Marketing (Americas)

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Polynovo is and its enterprise value is .

The PNV's stocks Beta value is 1.38 making it 38% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Polynovo (PNV)

Polynovo (ASX:PNV) Frequently Asked Questions

1. What is Polynovo's Stock Symbol?

Polynovo trades on ASX under the ticker symbol "PNV".

2. What is Polynovo's stock price today?

One share of PNV stock can currently be purchased for approximately $1.99.

3. How can I contact Polynovo?

Polynovo's mailing address is 320 Lorimer Street Unit 2 Port Melbourne VIC 3207 Australia. The company can be reached via phone at 61 3 8681 4050.

4. What is Polynovo's official website?

The official website of Polynovo is https://polynovo.com.

5. Which share registry manages Polynovo's stock?